• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Dyadic International, Inc.

    < Previous 1 2 Next >
    Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic Expands Global Presence with Participation in Key Industry Events
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Attend Industry Events in June
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Attend Industry and Investor Events in May
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic Announces Change in Board and Management Leadership Roles
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Attend Industry Events in April
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Attend Industry Events in March
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI MRVI
    Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic Attends Investor Events in December
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Present at Industry Events in November
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic Appoints Doug Pace to Its Executive Leadership Team
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic’s C1 Platform Selected by the Vaccine and Immunotherapy Center (“VIC”) at Massachusetts General Hospital as Part of VIC’s $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic to Present at Industry and Investor Events in October
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells
    From Dyadic International, Inc.
    Via GlobeNewswire
    Tickers DYAI
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.